Element5 Announces The Appointment Of Post-Acute Care industry leader, Jennifer Maxwell To Board Of Directors
Jennifer Maxwell serves as the co-founder and co-CEO of Maxwell Healthcare Associates
Element5, an Automation as a Service solution leveraging AI and RPA for post-acute care, announced the appointment of Jennifer Maxwell to their Board of Directors. Jennifer is currently the co-founder and CEO of Maxwell Healthcare Associates, (MHA) an industry leading consulting firm in post-acute care and Strategic Advisor to Medalogix, a one-of-a-kind data analytics company also in the post-acute care space. With the addition of Jennifer Maxwell to its board of directors, Element5 aims to strengthen its technology leadership and accelerate the adoption of AI (Artificial Intelligence) & RPA (Robotic Process Automation) based solutions across the post-acute care industry.
“We’re thrilled to add Jennifer Maxwell to our Board of Directors,” commented Joe Randesi, co-founder & CEO of Element5. “Jennifer’s deep expertise in the post-acute care industry has steered organizations like Maxwell Healthcare Associates and Muse Healthcare across new frontiers. Her seasoned insights and experience will be valuable as Element5 pursues our mission to lower the cost of care by removing the burden of labor-intensive, repetitive tasks.”
Jennifer Maxwell has also served as president of Muse Healthcare, Executive Director of the Minnesota Homecare Association and Division Director for Mesa County Department of Human Services. This combined experience over her career has helped clients and organizations to achieve new heights of operational, technological, regulatory and financial efficiencies.
Speaking on her appointment, Jennifer Maxwell said, “I am excited to join the Element5 board of directors. I strongly believe in the work that Element5 is doing as they radically change the healthcare industry by optimizing efficiencies and creating better outcomes. I look forward to working with the team to achieve their next level of success.”
Last year, Element5 announced the closing of its seed round of funding, with a commitment to simplify the adoption of RPA for post-acute care. Element5 delivers end-to-end workflow automation-as-a-service by programming software robots to complete work as if they are humans, leveraging AI and RPA technologies.